Whit Mayo
Stock Analyst at Leerink Partners
(2.51)
# 2,318
Out of 5,140 analysts
152
Total ratings
52.58%
Success rate
10.66%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Downgrades: Market Perform | $25 → $14 | $14.33 | -2.30% | 11 | Dec 3, 2025 | |
| MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $22.07 | -22.97% | 11 | Sep 5, 2025 | |
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $369.88 | -16.19% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $2.95 | -15.25% | 5 | Mar 31, 2025 | |
| AHCO AdaptHealth | Maintains: Buy | $12 → $11 | $10.52 | +4.56% | 11 | Feb 13, 2025 | |
| EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $10.74 | -25.51% | 2 | Nov 19, 2024 | |
| ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $8.54 | +192.74% | 2 | Nov 12, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $270.67 | -7.64% | 12 | Oct 2, 2024 | |
| EHC Encompass Health | Initiates: Outperform | $100 | $99.41 | +0.59% | 1 | Jul 10, 2024 | |
| BTSG BrightSpring Health Services | Initiates: Outperform | $15 | $39.23 | -61.76% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $347.75 | +61.04% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $203.68 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $126.91 | -23.57% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $274.91 | +21.86% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $465.44 | -38.55% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $15.47 | +158.56% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $23.60 | +65.25% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $2.62 | -42.75% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $0.95 | +3,047.62% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $190.83 | -71.18% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $88.94 | +96.76% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $23.30 | -18.45% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.27 | +22.32% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $269.14 | -24.57% | 2 | May 1, 2018 |
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Market Perform
Price Target: $25 → $14
Current: $14.33
Upside: -2.30%
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $22.07
Upside: -22.97%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $369.88
Upside: -16.19%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $2.95
Upside: -15.25%
AdaptHealth
Feb 13, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $10.52
Upside: +4.56%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $10.74
Upside: -25.51%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $8.54
Upside: +192.74%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $270.67
Upside: -7.64%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $99.41
Upside: +0.59%
BrightSpring Health Services
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $39.23
Upside: -61.76%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $347.75
Upside: +61.04%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $203.68
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $126.91
Upside: -23.57%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $274.91
Upside: +21.86%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $465.44
Upside: -38.55%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $15.47
Upside: +158.56%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $23.60
Upside: +65.25%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $2.62
Upside: -42.75%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $0.95
Upside: +3,047.62%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $190.83
Upside: -71.18%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $88.94
Upside: +96.76%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $23.30
Upside: -18.45%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.27
Upside: +22.32%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $269.14
Upside: -24.57%